We have an ongoing programme investigating different aspects of systemic sclerosis treatment and, in particular, of digital (finger and toe) ulceration and telangiectases (small dilated blood vessels near the surface of the skin).
Intense pulsed light (IPL)
We have recently completed a clinical study comparing IPL and laser treatment of systemic sclerosis-related telangiectases.
Patients attending Salford Royal Hospital are also recruited into multicentre studies assessing different aspects of the disease process and its features.
- Comparison of intense pulsed light and laser treatment of telangiectases in systemic sclerosis (PDF)
- A double-blind placebo-controlled crossover trial of the alpha-2C adrenoceptor antagonist (PDF)